Variables | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95 % CI) | p value | HR (95 % CI) | p value | |
Age <40 years | 0.6 (0.2–2.4) | 0.51 | 1.2 (1.5–9.7) | 0.88 |
T stage, T2 (vs. T1) | 1.8 (0.9–3.2) | 0.12 | 2.1 (0.3–5.7) | 0.54 |
Positive LN | 3.6 (1.5–11.3) | 0.02* | 6.9 (1.2–38.4) | 0.03* |
Stage, IIB-IIIA | 4.8 (1.2–19.6) | 0.03* | 4.9 (1.6–29.3) | 0.02* |
IBTR | 21.9 (4.7–101.9) | <0.001* | 31.8 (6.1–165.3) | <0.001* |
Positive margin status | 1 | 0.85 | 1 | 0.93 |
Omission of Radiotherapy | 1 | 0.78 | 1 | 0.92 |
Negative ER | 1.6 (0.5–4.4) | 0.40 | 3.1 (0.7–12.3) | 0.12 |
Negative PR | 1.8 (0.7–4.9) | 0.26 | 3.4 (0.8–14.3) | 0.09 |
Positive HER2 | 1.2 (0.1–8.3) | 0.92 | 1 | 0.95 |
Positive LVI | 1.2 (0.2–1.3) | 0.84 | 2.3 (0.3–18.8) | 0.43 |
Positive Ki-67 | 1.1 (0.4–2.9) | 0.87 | 1.5 (0.3–5.9) | 0.64 |
High histologic grade | 1 | 0.84 | 1 | 0.97 |